🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchClinicalTrials.gov GLP-1 trial tracker — updated weekly Page 13

ClinicalTrials.gov GLP-1 trial tracker — updated weekly

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 255 replies 53,106 viewsPage 13 of 20
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Feb 27, 2024 at 10:25 AM#61

Agreed. My doctor said the same thing about ClinicalTrials.gov.

2 20steve_okc, dave_SLC
Reply Quote Save Share Report
InsuranceTom
Senior Member
1,345
7,890
Mar 2024
Connecticut
Feb 27, 2024 at 10:42 AM#62

Slightly tangential to ClinicalTrials.gov GLP-1 but oliver_london reminded me — has anyone else noticed changes in their alcohol tolerance?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: Feb 27, 2024 at 3:42 PM
18 10lucas_SP_BR, lisa_labSD, adam_van and 15 others
Reply Quote Save Share Report
PharmacoVig_BOS
Senior Member
1,567
8,901
Feb 2024
Boston, MA
Feb 27, 2024 at 10:59 AM#63

+1. This mirrors my journey exactly. The ClinicalTrials.gov discussion here is so valuable.

36 1DataDave, Dr.GutHealth, amsterdam_pete and 33 others
Reply Quote Save Share Report
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Feb 27, 2024 at 11:16 AM#64

Slightly tangential to ClinicalTrials.gov GLP-1 but oliver_london reminded me — what is the latest on the oral formulations?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

1 0HPLC_Greg
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Feb 27, 2024 at 11:33 AM#65

Subscribing to this thread. ClinicalTrials.gov GLP-1 is exactly what I've been researching. 🙏

6 12LarryQC_SD, wanda_boise, NurseAsh_DET and 3 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register